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Gold nanoparticles (AuNPs) can be functionalized with a wide variety of 
molecules through electrostatic, hydrophobic, or thiol-gold affinity interactions. AuNP 
conjugates combine the unique properties and functions of both the nanoparticle and 
the additional molecules. The ykkCD riboswitch serves as a regulator for a multidrug-
resistance efflux pump. This riboswitch was first discovered in B. subtilis and specifically 
recognizes tetracycline family of antibiotics. 
Our research is focused on attaching the riboswitch aptamer to well-
characterized AuNPs and demonstrating that ykkCD remains functional following 
attachment. Future applications of this research include the delivery of tetracycline to 
resistant bacteria. 
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Process Analysis Essay 
For my Honors thesis project, I performed research investigating the structure 
and function of the ykkCD riboswitch and of gold nanoparticles. The ykkCD riboswitch 
is a regulator for a multidrug-resistance efflux pump, which means that it allows certain 
bacteria to resist the effects of antibiotics. Antibiotic resistance is a growing problem in 
the healthcare field; it causes many deaths and creates millions of dollars of extra 
healthcare spending. In order to reduce the effects of antibiotic resistance, it is critical 
for researchers to learn more about the ways bacteria defend against drugs and toxins. 
This project provides new information on the topic and the results of this investigation 
will help prevent the effects of resistant bacteria. 
The research presented in this project spans multiple semesters and represents 
numerous hours of lab work. The project involves techniques from both biotechnology 
and nanotechnology. The biotechnology portion of this project included synthesizing, 
purifying, and analyzing the DNA and RNA samples. The nanotechnology aspect of the 
project included synthesizing and purifying gold nanoparticles. These different fields 
came together in this project. This research process was helpful in developing technical 
skills that will be useful in my graduate study. I also think that this hands-on approach is 
a good way for me to learn about complex scientific methods. This project was 
challenging because it contained many difficult concepts and procedures, but through 
hard work I was able to complete this thesis. This project is meaningful because it 
makes a contribution to the global knowledge base of information regarding antibiotic 
resistance. I hope this work will be used by other researchers in the future to prevent 
the spread and the effects of antibiotic resistance. 
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Introduction 
RNA Nanotechnology 
Nanotechnology is the creation and application of materials on a nanometer 
scale. Applications of nanotechnology are seen in electronics, alternative fuel 
development and medicine. Historically, DNA and proteins have been most extensively 
studied for applications in medical nanotechnology. Within the last ten years, RNA has 
become a viable alternative material for nanoconstruction. RNA has become popular in 
research because it "can be designed and manipulated with a level of simplicity 
characteristic of DNA, meanwhile displaying flexibility in structure and diversity in 
function similar to that of proteins" (Guo 2). 
In addition to its simultaneous diversity and simplicity, RNA provides many other 
advantages. RNA can self-assemble in a highly controlled and programmable manner. 
Self-assembly is a spontaneous process where a pre-existing sequence of nucleotides 
can form an organized structure consisting of a network of noncovalent interactions (Bui 
7). RNA self-assembly is programmable and tertiary structure formation can be altered 
through the addition of ionic salts. RNA can also be produced easily and in large 
quantities. RNA is useful in biological applications because it can pass through the 
nuclear membrane of cells and regulated biological pathways. 
For RNA to be a useful therapeutic tool, it can interact with nanoparticles to 
increase stability and gain the ability to enter human cells and tissues. Free, unmodified 
RNA is extremely unstable and is quickly degraded by nucleases when delivered into 
mammalian cells. This project focuses on using gold nanoparticles to act as a 
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supporting structure for the RNA so the macromolecule can be used in human tissues. 
Gold nanoparticle/RNA conjugates bring together the unique properties and functions of 
both materials (Figure 1 ). Conjugates can be easily created through the affinity 
interactions between the positively charged gold and negatively charged thiolated 
biomolecules. This attachment method is preferred because it leaves the native 
structure of the RNA intact. This allows the activity, selectivity, and specificity of the 
RNA structure to remain unaffected. 
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Figure 1 - Graphical abstract designed to highlight various applications of gold 
nanoparticles with different kinds of macromolecule conjugates- adopted from DeLong 
eta/ 
Nanoparticles 
Nanoparticles are particles of any shape with dimensions between 1 o-9 and 1 o-7 
m and can form from many different materials. Categories of nanoparticles include 
carbon nanotubules, dendrimers, and metallic nanoparticles (Medina et al 553). This 
3 
project focuses on metallic nanoparticles, specifically, functionalized gold nanoparticles 
(Figure 2). 
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Figure 2 - Common classes of Nanoparticles 
Properties of the conventional materials change when they are converted into 
nanoparticles. In conventional materials, the percentage of atoms at the surface is 
much smaller than the total number of atoms in the sample. At the nanometer scale, 
materials have a large surface area compared to total mass. This relationship can 
result in changes in the physical properties of the material. Nanoparticles have different 
visual appearances than their conventional counterparts. For example, gold 
nanoparticles appear a deep red color in solution, instead of gold. Other physical 
properties, such as malleability or ductility also change on the nanometer scale. These 
physical changes allow nanoparticles to be used in applications where conventional 
materials are ineffective. This project utilizes the nanoscale properties of gold to create 
functional conjugates of nanoparticles and RNA. 
After the attachment of biological molecules, the functionalized particles can be 
used in gene therapy, as homing molecules, chemical detectors, or to create novel 
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materials and structures. For example, conjugates formed with RNA can be 
used to regulate gene expression. Conjugates formed with aptamers can be used to 
target a nanoparticle to a given cell type. 
Riboswitches 
Riboswitches are highly conserved sections of mANA that can bind to small 
molecular ligands to regulate gene expression without the help of protein factors. 
Binding to the ligand induces structural changes in the riboswitch, which then controls 
expression of genes. This can either attenuate or upregulate transcription and 
translation, depending on the type of riboswitch. The general structure of a riboswitch 
consists of three components: aptamer, expression platform, and switching sequence. 
The aptamer is responsible for ligand binding. The expression platform is directly 
involved in altering transcription and translation of a downstream gene. The switching 
sequence lies between the aptamer and expression platform and can bind to both other 
components. While the general structure of a riboswitch is similar in all varieties, there 
is a high degree of diversity in the possible size and complexity. In addition to the wide 
range of structures, there are many different types of ligands that riboswitches can 
interact with. Currently, 20 different classes of riboswitches have been identified with 
specificity to a group of ligands (Figure 3). There are other riboswitch-like genetic 
control elements that lack a validated ligand, and this group is referred to as "orphan 
riboswitches." 
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This project focuses on the ykkCD riboswitch, which is a type of orphan riboswitch that 
was first discovered in B. subtilis. ykkCD appears to be a transcriptional ON-switch that 
regulates the expression of a multidrug-resistance efflux pump (ykkCD pump). This 
riboswitch specifically recognizes the tetracycline family of antibiotics. Ligand binding 
unfolds the terminator stem and permits the expression of the ykkCD pump, which 
expels the toxins from the cell. ykkCD was chosen for study because it has numerous 
innovative practical applications in the area of nanotechnology as a highly sensitive tet 
sensing module or a tat-responsive regulatory switch. 
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Figure 4 - Predicted Secondary Structure of ykkCD Riboswitch 
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Modifications to ykkCD 
For ykkCD to be used as a tet-sensor or artificial switch in medically useful 
nanodevices, it must be able to remain stable and functional in conditions found in 
mammalian cells. There are ribonucleases in mammalian cells that will rapidly degrade 
bacterial RNA. To increase stability, different modifications will be made to the ykkCD 
RNA. One way to modify the RNA is by replacing UTP with deoxy UTP (dUTP). 
Another way to reduce the potential for degradation by ribonucleases is to substitute 
2'Fiuoro derivatives for pyrimidine nucleotides. The presence of the 2'-fluoro in the 
RNA leads to increased chemical stability at high pH, increases binding affinity, and 
improves nuclease resistance (Bui 13). The natural 2'0H is replaced by the 2'F, which 
prevents the OH from acting as a nucleophile and cleaving the adjacent phosphate 
(Figure 5). 
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This self-cleaving results in degradation of the RNA. Substitution of the of 2'-fluoro in 
the RNA structure does not significantly affect the conformation of the sugar ring, 
allowing the RNA to function the same as the natural version (Figure 6 & 7). 
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Figure 6- Structure of 2'F-dCTP 
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Figure 7- Structure of 2'F-dUTP 
The effectiveness of the modifications can be tested by incubating the RNA in fetal 
bovine serum, which contains high levels of ribonucleases. If the modifications are 
successful, then the RNA will degrade at a slower rate than the unmodified version. 
These modifications were chosen because the impact on 30 structure and binding is 
expected to be minimal (Sui 13). The structure of the ykkCD must remain relatively 
unchanged for it to retain its specificity for tetracycline. 
Project Applications 
The medical significance of this project arises from the fact that ykkCD is a tet-
responsive regulator of resistance bacteria. If the underlying mechanism of antibiotic 
sensors like ykkCD can be understood, it will provide opportunities to suppress 
resistance mechanisms and innovate new nanotechnology applications. 
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Bacterial resistance is a growing problem in the medical field. According to the 
CDC, 70% of bacterial strains are resistant to at least one antibiotic. Methicillin-
resistant Staphylococcus aureus (MRSA) is one of the most common resistant strains 
and is responsible for 369,000 hospitalizations, 19,000 deaths, and $4 billion in health-
related spending each year in the United States. The ykkCD riboswitch used in this 
project is found in B. subtilis. ykkCD functions to regulate expression of an efflux pump, 
which removes antibiotic from the bacteria, allowing it to resist tetracycline and continue 
to infect the patient. Studying ykkCD can lead to the development of new methods to 
treat bacterial infections that will bypass the efflux pump defense mechanism. 
The nanotechnology applications of ykkCD include use as a highly sensitive tet 
sensing module or a tat-responsive regulatory switch. Short term goals include using 
ykkCD as a tat-delivery capsule to treat infections caused by tat-resistant bacteria. By 
caging tetracycline in the ykkCD aptamer, it may avoid recognition by the resistance 
mechanisms in bacteria. If the tetracycline avoids detection, then the drug can again be 
useful as a therapeutic. Long term goals include utilizing the highly sensitive binding 
site for various applications. Binding affinity measurements show that ykkCD has a 
binding affinity of 2.4nM, meaning that it can detect an extremely small amount of tet 
molecules within a B. subtilis cell. ykkCD can be modified to respond to man-made 
signals. It can also function as a tat-responsive molecular scissor that degrades 
harmful compounds in a tat-dependent manner. Finally, once the molecular basis of the 
extreme sensitivity is understood, the specificity of ykkCD can be altered and it can be 
used as a caging compound for targeted drug deliveries. 
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Research Objectives 
This project focused on attaching ykkCD to well-characterized gold nanoparticles 
and working to improve the stability of the RNA in mammalian cell environments. The 
first stage in creating a medically useful conjugate is developing a method of attaching 
ykkCD to well-characterized nanoparticles. The RNA will be linked to the nanoparticles 
using a sulfydryl modified DNA oligonucleotide that is designed to be complementary to 
nucleotides 85-1 06 of ykkCD. This region of ykkCD is not believed to be functional in 
tet sensing, so the attachment of the oligonucleotide should not alter the specificity of 
the riboswitch. SH functionalized oligonucleotides have also been demonstrated to 
form stable interactions with gold nanoparticles. ykkCD is attached to the oligo through 
a heat annealing process that allows the bases of the riboswitch to form hydrogen 
bonds to the oligonucleotide. To test if the attachment to the nanoparticle is successful, 
several different methods can be used. First, a gel shift can show if the RNA and oligo 
complex has attached to the nanoparticle. If the RNA is successfully attached to the 
nanoparticle, it will increase the overall size of the particle. This will cause a sample of 
functionalized gold nanoparticles to move at a slower rate than nanoparticles alone. 
The size of the particles can also be measured using dynamic light scattering (DLS). If 
the attachment process is successful, the dynamic light scattering will show an increase 
in size between the naked gold nanoparticle and the nanoparticle conjugates. In 
addition to the gel shift and DLS, the attachment of the RNA to the nanoparticle will alter 
the UV-Vis spectra of the naked nanoparticle. 
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Project Goals 
As we stated earlier, the riboswitch must be modified to protect it from 
ribonucleases and attached to well-characterized nanoparticles to increase 
bioavailability. This project focuses on modifying the ykkCD using dUTP bases and 2'-
Fluoro RNA oligonucleotides. The stability of the modified RNA will be assessed by 
incubating the samples in fetal bovine serum. The level of degradation of the samples 
will indicate how if the modified RNA samples are more stable than the unmodified 
version. Then the resulting modified RNAs will be attached to gold nanoparticles 
(Figure 8). The conjugates will be purified and used in functional tests. 
+oligo 
Oligo 
Figure 8- Schematic of the attachment of ykkCD and AuNP (green hexagon represents 
tetracycline) 
Materials and Methods 
Section 1: DNA and RNA synthesis 
Large scale PCR to make ykkCD riboswitch template DNA 
A polymerase chain reaction (PCR) technique was used to create large 
quantities of ykkCD riboswitch templates. The components listed in table 1 were 
combined and mixed in a 1 .5 ml centrifuge tube. 100 pl aliquots were transferred into 
10 separate 0.5 ml microcentrifuge tubes, which were then placed into the PCR 
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machine. The PCR program listed in table 2 was used to amplify the DNA and create 
ykkCD riboswitch templates. Following completion of the program, an 181 Scientific 
PCR cleanup kit was used to purify the resulting riboswitch templates according to the 
instructions of the manufacturer. 
Table 1. Components for a 1 mL PCR reaction 
1 pl ykkCD riboswitch DNA template 
10 pl 100 pM primer (top) 
10 pl 100 pM primer (bottom) 
200 pl 5x reaction buffer 
20 pl dNTP mixture 
739 pl millipore water 
20 pl DNA polymerase 
Table 2. PCR program details 
Temperature Time Function 
Step 1 98°C 30 minutes 
Step 2 98°C 5 minutes Separate DNA 
strands 
Step 3 39°C 5 minutes Anneal primers 
Step4 72°C 15 minutes Amplification of 
DNA 
Repeat steps 1-4 for 35 cycles 
Step 5 72°C 1 minute Final amplification 
Step 6 4°C Overnight Storage 
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RNA synthesis using PCR DNA templates 
Large amounts of ykkCD RNA were produced using the DNA templates and T7 
RNA polymerase. The reagents listed in table 3 were combined into a 1.5mL 
microcentrifuge tube. The reaction mixture was placed into a 37°C water bath for two 
hours. After two hours, 1 OpL of RNase free DNase was added to eliminate any 
remaining DNA templates. The reaction mixture was incubated for an additional 30 
minutes. After 30 minutes, 50pL of EDTA was added. The concentration of the RNA 
was measured using UV spectroscopy. This protocol typically produced RNA samples 
with a concentration of 150-200 ng/pL. Samples were stored at -20°C until needed. 
Table 3. Reagents for a 500 pL transcription reaction mixture 
50 pL 1 Ox reaction buffer 
1 0 pL 1 0 mM rNTP mixture 
10 pg DNA (from purified PCR product- volume varies with concentration) 
25 pL 1 OOmM OTT 
50 pL T7 Polymerase (Epicentre, catalog no. TH950K) 
Add Millipore H20 until reaction mixture reaches 500 pL 
Synthesis of dUTP modified ykkCD RNA 
The ykkCD RNA was prepared using dUTP instead of rUTP to increase its 
stability. The reagents in table 4 were combined according to the instructions provided 
by the manufacturer in a 1.5mL microcentrifuge tube. The polymerase used in this 
synthesis was an Epicentre T7 R&DNA TM polymerase, which was chosen due to its 
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ability to incorporate modified bases into the transcription products. The tube was 
incubated in a 37°C water bath overnight. After the incubation period, the dUTP RNA 
was purified using either standard column purification or gel purification protocol. 
Following the purification protocol, the concentration of the dUTP RNA sample was 
checked using UV spectrometry. This protocol typically produced samples of dUTP 
RNA with a concentration of 5-25 pg/pl. 
Table 4 - Reagents for a 500 pL dUTP RNA transcription reaction mixture 
SOpL 1 OX reaction buffer (provided by manufacturer) 
25 pl 10 mM dUTP 
25 J.JL 10 mM rATP 
25 J.JL 10 mM rGTP 
25 pl 1 0 nM rCTP 
2.5 J.JL 1M MnCI2 
2.5 pg DNA template 
25 pl 1 00 mM OTT 
so J.JL T7 R&DNA TM Polymerase (Epicentre, catalog no. D7P9205K) 
Millipore H20 to 500 pl 
Synthesis of 2 'F modified ykkCD RNA 
The ykkCD RNA was prepared using 2'F rUTP and 2'F rCTP to increase its 
stability. The reagents in table 5 were combined according to instructions provided by 
the manufacturer in a 1.5ml microcentrifuge tube. The polymerase used in this 
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synthesis was an Epicentre T7 R&DNA TM polymerase, which was chosen due to its 
ability to incorporate modified bases into the transcription products. The tube was 
incubated in a 37°C water bath overnight. After the incubation period, 1 Opl RNA-free 
DNase was added to the tube and then it was incubated for an additional 30 minutes at 
37°C. Next, 100pl of 0.25M EDTA (pH=8) was added. The 2'F RNA was purified using 
either standard column purification or gel purification. The concentration of the sample 
was then measured using UV spectrometry. 
Table 5 - Reagents for a 500 pL 2'F RNA transcription reaction mixture 
50 pl 1 OX reaction buffer (provided by manufacturer) 
5 pl 50mM 2'F dUTP 
5 pl 50mM 2'F CTP 
5 pl 1 OmM rGTP 
5pL10mM rATP 
2.5 pl 1M MnCI2 
2.5 pg DNA template 
25 pl 1 OOmM DTI 
50 pl T7 R&DNA TM Polymerase (Epicentre, catalog no. D7P9205K) 
Millipore H20 to 500 pl 
Section 2: DNA and RNA purification 
Purifying PCR Products using column purification 
The DNA templates produced using PCR were purified using an 181 Scientific 
Gei/PCR DNA Fragments Extraction Kit (Cat. No. 1847020). The samples were purified 
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using the protocol outlined by the manufacturer. After purification, the concentration of 
the template samples was checked using UV spectrometry. After this process, the 
riboswitch templates were stored at -20°C until needed for production of ykkCD RNA 
samples. This protocol typically produced purified DNA samples with a concentration of 
approximately 150 ng/pL. 
RNA purification using column purification 
The transcription products were purified to remove any contamination from the 
RNA samples, including low molecular weight degradation products. Thermo Scientific 
GenJet RNA purification columns and the accompanying manufacturer instructions 
were used to purify the RNA. The concentration of the RNA was determined using UV 
spectrometry. The absorbance of the sample at 260 nm was multiplied by the specific 
molar extinction coefficient to find the concentration of the RNA sample. The specific 
molar extinction coefficient for the ykkCD RNA is 1149800. 
Check RNA purity using polyacrylamide gel electrophoresis 
To ensure that the RNA sample is free of degradation products, the samples 
were resolved using denaturing polyacrylamide gel electrophoresis (PAGE). A 20% 
denaturing urea gel and urea dye were prepared using standard protocols. Prior to 
loading the samples, the gel was pre-run for 30 minutes at 15W using a 0.5X TBE 
running buffer. The samples were prepared by adding 5pl urea dye to 5pl RNA. The 
sample was boiled on a 1 00°C heat block for 5 minutes and then were spun for 30 
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seconds on the centrifuge. After the gel pre-run was complete, the RNA samples were 
loaded into the wells. The gel was then run at 15W for 30 minutes. 
After the electrophoresis step, the gel was removed from the glass plates and 
placed into a plastic container filled with 1 OOmL O.Sx TBE. 1 OJ.ll ethidium bromide was 
added to the container; it was placed on an orbital shaker for 1 0 minutes to stain the 
gel. Finally, the gel was photographed using the Bio-Rad gel imager. The RNA sample 
is pure if there is a single band on the gel. If there are multiple bands, that indicates 
that there are other types of DNA or RNA in the mixture. 
Gel purification of RNA products 
Gel purification was used to separate full length RNA from its degradation 
products; the full-length RNA was excised and eluted from the gel. 
Sample Preparation 
To prepare the samples for gel purification, the RNA was precipitated using a 
salt/ethanol mix and dried using the speed vac. After drying, the RNA was combined 
with urea dye. The sample was resolved on a 20% denaturing gel, which was run for 1 
hour at 15W. 
Gel Excision 
First, the urea gel was removed from the glass plates and placed on clean plastic 
wrap. The gel was then placed above fluorescent paper and a UV light was directed 
onto the sample, showing the full length RNA as a dark line. The band of RNA was cut 
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from the gel using a sterilized razor blade. The gel excision was placed into a syringe 
and was crushed into a 2ml centrifuge tube. 
RNA Elution 
After the gel excision, elution buffer was used to elute the RNA from the crushed 
gel. 1 ml of 1X TBE (tris borate, EDTA pH= 8.0) elution buffer and 1 ml of 
phenol/cholorform was added to the crushed gel. The sample was incubated at 37°C 
for 2 hours. Following incubation, the sample was centrifuged at maximum speed for 2 
minutes. The top layer of the sample was transferred to a clean 2 ml centrifuge tube, 
which was then placed on ice. An additional 2 ml of elution buffer was added to the 
original tube. The sample was incubated for an additional 2 hours at 37°C. After the 
second incubation, the sample was centrifuged at maximum speed for 2 minutes. The 
top layer of the sample was placed into a clean 2 ml tube, which was then placed on 
ice. 
Ethanol precipitation of elution fractions 
Ethanol precipitation was used to collect the RNA from the elution fractions. 
500tJL of chloroform was added to each of the elution fractions. Each tube was 
vortexed for 1 minute and then centrifuged for 2 minutes. The top layer of each fraction 
was transferred to a new 2 ml tube. The following components were added to each of 
the 2ml tubes: 
• 1 OOtJL 3M Na-acetate (pH=5.3) 
• 1 mL isopropanol 
• 1 tJL glycogen 
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Next, the samples were incubated at -20°C overnight. 
RNA precipitation 
After the samples were incubated overnight, they were allowed to thaw and then 
were centrifuged for 30 minutes at maximum speed. The supernatant was removed 
and 1 OOJJL of cold 75% EtOH was added to the tube. The samples were then 
centrifuged for 5 mintues at maximum speed and then the supernatant was removed. 
The pellet was then dried in the speed vac for 5 minutes and then resuspended in 
100JJL TE. 
Gel purified RNA purity check 
After the RNA was precipitated, its purity was checked using a urea gel. The gel 
was prepared using the same protocol as outlined above. 5JJL of the purified RNA was 
loaded into the well and the gel was run for 30 minutes at 15W. The gel was then 
removed from the glass plates and placed into a plastic container with 1 OOmL 0.5X TBE 
and 1 OJJL Ethidium Bromide. The container was placed on a mutator for 5-10 minutes 
and then photographed using the BioRad gel imager system. 
Section 3: AuNP synthesis and purification 
Synthesis of Aqueous Citrate-Protected Gold Colloid 
The Tanton protocol was followed to perform a simple synthesis of aqueous gold 
nanoparticles surrounded by shells of coordinated citrate anions (Tanton 6). In this 
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protocol, sodium tetracholoraurate (NaAuCI4) is reduced by a citrate salt to yield 
particles approximately 15 nm in diameter. 
Materials: 
• Aqua regia: 3:1 (v/v) concentrated HCI/concentrated HN03 
• 1 mM HAuCI4 
• 38.8 mM sodium citrate 
• 500 mL round-bottom flask 
• Reflux condenser 
• Heating mantle 
• 0.45-Jlm nylon filter 
Procedure: 
First, all of the glassware involved in the process was washed thoroughly with 
aqua regia and then with water. After washing, the glassware was assembled on a 
heating mantle and magnetic stirrer. A large stir-bar was added to the 500mL round-
bottom flask. The flask was charged with 250 mL of 1 mM NaAuCI4 and the solution 
was brought to reflux with vigorous stirring. Next, 25mL of 38.8 mM sodium citrate was 
added to the round bottom flask. The sodium citrate was added as rapidly as possible. 
The addition of the sodium citrate resulted in the solution changing from a yellow to 
purple color. The solution remained in reflux for 20 minutes. By the end of the reflux 
period, the solution was a deep red color. The solution was then cooled to room 
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temperature and filtered through a 0.45 pm nylon filter. The nanoparticle solution was 
stored at room temperature in a dark glass container. 
Section 4: Conjugation and Purification of AuNPs 
Preparation of Gold Nanoparticle-DNA conjugates 
Materials: 
• oligonucleotide dissolved in water 
• aqueous gold nanoparticle solution 
• Bis(p-sulfonatophenyl)phenyl-phosphine dehydrate dipotassium salt (Aldrich) 
o Solid and 0.5 M aqueous solution 
• NaCI, solid and 1M aqueous solution 
• Methanol 
• 5x TBE electrophoresis buffer 
• 30% (vlv) glycerol 
Procedure: 
Complex nanoparticles with phosphine 
First, 2 mg phosphine was added to 10 ml gold nanoparticle solution. Three separate 
types of nanoparticles were used: nanoparticles that were produced in-house using the 
Tanton protocol, PELCO NanoXact 15nm AuNPs (Product No. 82150-15), and PELCO 
5nm gold colloid (Product No. 15702-20). This solution was rotated for 10 hours at 
room temperature on an orbital shaker at low speed. After 10 hours, solid NaCI was 
added to the tube to create a solution of approximately 2-3M NaCI, resulting in a color 
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change from deep burgundy to light purple. The particle solution was then centrifuged 
for 30 minutes at 500xg at room temperature to pellet the particles. After centrifugation, 
the supernatant was discarded and the particles were resuspended in 1 mL of 0.5 mM 
phosphine. 0.5 mL methanol was added to the particle solution. The solution was 
again centrifuged for 30 minutes at 500 x gat room temperature. After this 
centrifugation step, the supernatant was discarded and the nanoparticles were 
resuspended in 1 mL of 0.5 mM phosphine. 110 pL 5x TBE electrophoresis buffer was 
added to result in a final concentration of 0.5x TBE. The absorbance of the nanoparticle 
solution was measured using the nanodrop spectrometer. To find the concentration in 
molarity, the absorbance of the sample was multiplied by the extinction coefficient for 
the nanoparticles. 15nm nanoparticles have an extinction coefficient of 6.5x108 ; 5nm 
nanoparticles have an extinction coefficient of 4.5x107 . 
Heat anneal oligonucleotide and ykkCD RNA 
Equal concentrations of deprotected oligonucleotide and ykkCD RNA were combined in 
a microcentrifuge tube. The tube was heated at 1 oooc for 2 minutes. After heating, the 
tube was spun in the centrifuge for 30 seconds and then placed on ice for 10 minutes. 
Finally, 55pL 1M NaCI was added to the solution before adding the solution to the 
nanoparticles. 
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Conjugate nanoparticles and oligonucleotide 
First, an aliquot of oligonucleotide-ykkCD RNA solution was diluted in enough O.Sx TBE 
to make a final solution of SOJJM oligonucleotide. The oligonucleotide and nanoparticle 
solutions were then combined into a tube and mixed well. 0.05 vol of 1M NaCI was 
added to the tube; the tube was then placed on an orbital shaker at low speed and 
allowed to incubate for 16 hours. 
Purification of conjugates 
The Snm conjugates were resolved on a 1% agarose gel. Bands belonging to 
the conjugate were excised per the Tanton protocol. ykkCD-AuNP conjugates were 
recovered from the gel using electroelution. Finally, the absorbance of the sample was 
checked using UV spectrometry. The 15nm commercial AuNP conjugates were purified 
using a sequence of four 30-minute centrifugations. The conjugates were centrifuged; 
the supernatant was discarded and then the samples were resuspended in 1 OOJJL O.SX 
TBE. After the centrifugations, these conjugates were also analyzed using UV 
spectrometry. 
Section 5: End Point Stability Test 
Blood Serum Test - End-point Assay 
The blood serum test was used to compare the stability of unmodified ykkCD 
RNA and derivativized ykkCD RNA samples. The samples were prepared as follows: 
Unmodified RNA: 
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• 1JJL RNA 
• 1 pl 1 0% Fetal Bovine Serum or H20 (Control) 
• 2 pl 5x reaction buffer 
• 6 pl H20 
Total Volume = 10 pl 
dUTP RNA: 
• 5 pl dUTP RNA 
• 1 pl 10% Fetal Bovine Serum or H20 (Control) 
• 2 pl 5x reaction buffer 
• 2 pl H20 
Total Volume = 1 o pl 
2'F RNA: 
• 5 pl 2'F RNA 
• 1 pl 1 0% Fetal Bovine Serum or H20 (Control) 
• 2 pl 5x reaction buffer 
• 2 pl H20 
Total Volume= 10 pl 
After the reagents were combined, the samples were incubated for 1 hour in a 37°C 
water bath. 10 pl urea dye was added and the samples were placed on a heating block 
for 5 minutes at 1 00°C. After heating, the samples were resolved on a 10% denaturing 
gel. The gel was then placed in a container with 1 OOmL 0.5x TBE and 1 Opl Ethidium 
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bromide and placed on a mutator for 10 minutes. After staining, the gel was 
photographed using the BioRad gel imaging system. 
Determining the Time-Dependence of RNA Degradation 
Fetal bovine serum and ykkCD RNA samples were incubated in a 37°C water 
bath; 5 pL samples removed at time 0, 10, 20, 25, 40, 60 and 80 minutes. A control of 
ykkCD RNA mixed with water was left in the water bath for the full 80 minutes. The 
starting reaction volume was 40 pL and was composed of the following reagents were 
combined in a 1.5 mL microcentrifuge tube: 
• 1 OpL ykkCD RNA 
• 8 pL 5x reaction buffer 
• 4 pL 10% Fetal Bovine Serum 
• 18 pL H20 
After the reagents were mixed, a 5 pL sample was immediately removed (time= 0). 
The tube was placed in the water bath until 10 minutes had elapsed. At this point, an 
additional 5pL sample was removed from the reaction and was placed in a separate 
tube with 5 pL urea dye. The sampling procedure was repeated after 20, 25, 40, 60 and 
80 minutes had elapsed. Each 5pL RNA sample was placed into a clean 
microcentrifuge tube and mixed with 5pL urea dye. After mixing with the urea dye, the 
samples were placed on a 1 00°C heating block for 5 minutes and then were stored on 
ice until all samples had completed the process. After all the samples were removed 
and mixed with the urea dye, they were loaded into wells of a urea gel. The samples 
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were then run at 15W until the blue urea dye reached the bottom of the gels. The gel 
was then removed from the glass plates and placed in a container with 1 OOJJL 0.5x TBE 
and 1 OJJL EtBr. The gel was placed on a mutator for 10 minutes and then photographed 
with the BioRad gel imaging system. The volume of the bands was quantified using the 
lmageLab software program. This stability test was repeated for unmodified ykkCD 
RNA, dUTP modified RNA, and 2'F modified RNA. 
Section 6: Attachment Analysis 
Gel shifts, dynamic light scattering, and UV-Vis spectroscopy were used to test if 
the nanoparticles and RNA had successfully conjugated. 
Gel Shift Assay to Demonstrate RNA-AuNP Attachment 
If the attachment was successful, the AuNP conjugates would move more slowly 
than naked nanoparticles through an agarose gel. Multiple lanes of a 2% agarose gel 
were loaded with conjugate samples and were run at 150V for 30 minutes. The first 
well was filled with 20J1L naked AuNP and 4JJL 30% glycerol. The next well was filled 
with 20J1L dUTP + AuNP conjugate and 4JJL 30% glycerol. The third well was filled with 
20JJL 2'F + AuNP conjugates and 4JJL 30% glycerol. Gel shifts were also performed 
with the naked AuNP and the conjugate samples combined in a single well. In this 
case, 10JJL naked AuNP, 10J1L AuNP conjugates, and 4JJL 30% glycerol were combined 
and then loaded into the agarose gel. After the samples were run on the gel, the gel 
was photographed using the BioRad gel imaging system and the movement of the 
bands was compared. 
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Dynamic Light Scattering 
Successful conjugation of the RNA to the nanoparticle results in an increase in 
size. This size change can be detected using dynamic light scattering. Three different 
samples were tested: 
• Naked AuNP 
• AuNP + dUTP RNA 
• AuNP + 2'F RNA 
Individually, 1 OOpL of each sample was loaded into a glass cuvette and were placed 
into a Malvern Zetasizer nano DLS machine. The data was recorded and exported to 
Microsoft Excel for analysis. 
UV-Vis spectroscopy 
Attachment of the RNA to the nanoparticle would also result in changes in the 
sample's UV-Vis spectrum. Three separate samples were tested: 
• Naked AuNP 
• AuNP + dUTP RNA 
• AuNP + 2'F RNA 
Individually, the samples were loaded into a glass cuvette and were placed into a HP 
8452A Diode Array Spectrophotometer for UV-Vis analysis. The samples were tested 
in a wavelength range from 190 to 820 nm. The spectra data was then exported to 
Microsoft Excel for analysis. 
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Results 
Stability Tests 
The dUTP and 2'F modifications to ykkCD were tested for increased stability in 
fetal bovine serum. After incubation with the fetal bovine serum, the samples were 
loaded onto denaturing gels so that the fraction of intact RNA could be determined. The 
unmodified RNA showed virtually no intact RNA after the first minute. The RNA 
continued to degrade further over the remainder of the incubation period. Both modified 
RNA samples showed much higher percentages of intact RNA when incubated with the 
same concentration of fetal bovine serum. The fraction of intact RNA remaining after 
each incubation period is represented in Figure 9-12. 
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Figure 10- Unmodified RNA stability test 
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Purification Methods of RNA-AuNP conjugates 
The purification of the RNA-AuNP conjugates was adjusted based on the size of 
the particle. The purification of the Snm AuNP was most successful when it was 
resolved on a 1% agarose gel. The increase in the size between the naked AuNP and 
the conjugate was significant enough to create a shift on the gel. Thus, the conjugate 
could easily be separated from the naked particle. The change in size between the 
naked 15 nm AuNP and the 15nm conjugate was not significant enough to create an 
easily visible shift on an agarose gel. The best way to purify the 15nm particles was 
through a series of centrifugations and resuspensions. 
Evidence for Successful Attachment 
The ykkCD was successfully attached to the nanoparticles; this was shown 
through gel shifts, dynamic light scattering, and UV-Vis spectroscopy. When naked 
AuNPs and AuNP conjugates were resolved on a 2% agarose gel, there is a clear shift 
between the bands. As shown in figure 12, The bands with the dUTP and 2'F RNA 
1 2 3 
Figure 13 - Gel shift between naked AuNP and 
conjugates on a 2% agarose gel 
Lane 1 - Naked AuNP 
Lane 2- 2'F RNA+ AuNP 
Lane 3- dUTP RNA+ AuNP 
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attached to the nanoparticle moved a shorter distance through the gel than the 
nanoparticle alone. 
The sizes of the nanoparticles and the conjugates were compared using dynamic 
light scattering. There was an increase in size between the naked nanoparticle and the 
RNA conjugates. In the 15nm test, the conjugates with the 2'F RNA attached showed 
the largest increase in size (Figure 14). The dUTP RNA also increased the size of the 
conjugate, but it was a smaller change than the 2'F. The 5nm particles also showed an 
increase in size after the attachment of RNA. In the 5nm samples, the largest increase 
in size was caused by the addition of the dUTP (Figure 15). The addition of 2'F created 
a small increase in conjugate size. 
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Figure 14 - Dynamic light scattering size comparison of 15nm AuNPs and conjugates 
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Figure 15- Dynamic light scattering size comparison of Snm AuNPs and conjugates 
Table 6- Average conjugate size 
Sample 
15nm- Naked 
15nm- dUTP 
15nm- 2'F 
Snm- Naked 
Snm- dUTP 
Snm- 2'F 
Average Size 
23.29 
35.21 
60.74 
11.44 
12.18 
11.83 
Standard Deviation 
7.038 
16.14 
22.87 
3.918 
2.432 
2.903 
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UV-Vis spectroscopy was also used to illustrate evidence of successful 
attachment. The attachment of RNA to the AuNPs resulted in a change in the sample's 
UV spectrum. For the 15nm particles, the addition of the RNA drastically changed the 
shape of the peak at 520nm. The naked nanoparticles had a rounded peak at 520nm, 
while the conjugates had a flattened peak with a sharp drop in the 580-600nm range. 
This pattern was found for both the attachment of the 2'F and dUTP RNA. For the Snm 
nanoparticles, there was still a change in UV spectra, but it was not as pronounced as in 
the 15nm samples. The addition of RNA to the Snm nanoparticles resulted in the peak 
at 520nm becoming less sharp and increasing the width of the peak. The introduction 
of the RNA also increased the sample's absorbance in the 600-800nm range. The 
spectra for the 2'F and dUTP are again similar, but for the Snm samples, the peak for 
the dUTP is slightly sharper than the 2'F. (Fig. 16-19) 
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Figure 16 - UV-Vis spectrum comparison of 15nm AuNPs and dUTP conjugates 
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Figure 19- UV-Vis spectrum comparison of 5nm AuNPs and dUTP conjugates 
Discussion 
In this project, the ykkCD riboswitch was modified to increase its stability and 
then the riboswitch was attached to well-characterized gold nanoparticles. The two 
separate modifications to ykkCD included substituting deoxy UTP for the natural UTP 
base in some samples and replacing pyrimidine nucleotides with 2'Fiuoro derivatives in 
others. The RNA was then attached to gold nanoparticles using a linker 
oligonucleotide. To determine if the attachment was successful, the samples were 
analyzed using gel shifts, dynamic light scattering, and UV spectroscopy. 
Stability Tests 
To determine if the dUTP and 2'F modifications increased the stability of the 
RNA, several stability tests were performed. The RNA was incubated with fetal bovine 
serum and samples were taken at specific time intervals. The samples and a control 
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Figure 17- UV-Vis spectrum comparison of 15nm AuNPs and 2'F conjugates 
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(no FBS) were resolved on a urea gel, the arrangement of the bands gave an indication 
of the stability of the RNA. If the RNA remained intact, then the samples would show a 
band the same size and position as the control. If the RNA was degraded by the 
ribonucleases in the FBS, then there would be smaller bands that migrated further down 
the gel. This shows that the overall RNA structure was broken down into smaller 
pieces, which moved through the gel faster than the larger control sample. A visual 
inspection of the unmodified RNA shows that the sample was degraded almost 
completely after the first incubation period. The sample is broken up into many bands 
which migrated a significant distance down the gel, indicating a small size. Both the 
dUTP and 2'F modified samples show a much higher percentage of intact RNA 
throughout the duration of the incubation periods. The dUTP modified samples showed 
a small amount of degradation in the form of several faint bands that migrated down the 
gel. The 2'F modified samples displayed a very similar band pattern as the control 
sample. 
The results of the stability test were quantified using Bio-Rad lmagelab software. 
The volume of the band corresponding to the intact RNA was quantified and then a 
background measurement was subtracted from the measurement. The data was also 
controlled for the total amount of RNA loaded into each well. Next, the volume for each 
incubation period was divided by the volume of the control sample. The resulting data 
was then plotted in Figure 15. The chart illustrates the fraction of intact RNA over time. 
The unmodified RNA shows a very small fraction of intact RNA after the first incubation 
period. Both the dUTP and 2'F modified RNA displayed a much higher level of intact 
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RNA over the duration of the experiment. This indicates that the modifications made to 
the RNA were successful in protecting the structure from degradation by ribonucleases. 
This stability is critical if ykkCD is to function properly as a human therapeutic tool. If 
the RNA is not stable in the presence of ribonucleases, then it will be degraded soon 
after it is introduced to a mammalian environment and cannot work as a therapeutic 
tool. 
Attachment Analysis 
For ykkCD to be successfully used in human tissues, it is critical that the RNA 
remains bioavailable. Attachment of the RNA to the nanoparticles allows the complex 
to be engulfed by cells. The RNA was first attached to a linker oligonucleotide via a 
heat annealing process. The oligonucleotide was then connected to the nanoparticles 
through the thiol-gold affinity interactions. The attachment of the RNA to the 
nanoparticles was successful, and this was shown in three different ways. 
Gel shifts were used to determine if the RNA had successfully attached to the 
AuNPs. If the attachment was successful, then the conjugates will move through an 
agarose gel more slowly than just the nanoparticles alone. In this experiment, samples 
were resolved on a 2% agarose gel. Both the dUTP modified RNA and the 2'F modified 
RNA caused the conjugate samples to move through the gel more slowly than the 
nanoparticles alone. This indicates that the RNA was securely attached to the 
nanoparticle and the objective of the study was met. 
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Attachment of the RNA was also analyzed using dynamic light scattering (DLS). 
Dynamic light scattering is a process that assesses the size of particles by directing a 
light source at a solution and analyzing the intensity and the pattern of light that scatters 
after hitting the particles. If the attachment is successful, then a comparison of the 
naked nanoparticle and a RNA conjugate will show an increase in size. The dynamic 
light scattering test also indicated that the attachment process was successful for both 
types of nanoparticle. The 15nm nanoparticle tests showed that the attachment of the 
RNA significantly increased the size of the particles. The addition of the 2'F RNA 
increased the average size from 23.29 ± 7.038 nm to 60.74 ± 22.87 nm. The addition of 
the dUTP RNA increased the average size from 23.29 ± 7.038 nm to 35.21 ± 16.14 nm 
assuming that the structures were spherical in shape. The 5nm commercially produced 
nanoparticles measured 11.44 ± 3.918 nm using DLS. When the 2'F RNA was 
attached, there was a slight size increase from 11.44 ± 3.918 nm to 11.83 ± 2.903 nm. 
The dUTP RNA also increased the size of the conjugates slightly, from 11.44 ± 3.918 
nm to 12.18 ± 2.432 nm. The increases in size shows that the RNA was successfully 
attached to the gold nanoparticles. 
The final way that the attachment of the nanoparticles was analyzed was using 
UV-Vis spectroscopy. If the RNA was successfully attached, it would cause a change in 
the UV-Vis spectra of the sample. The naked AuNP was expected to have a well-
defined peak at 520 nm. For the 15nm particles, the addition of the 2'F and dUTP RNA 
caused distinct changes to the UV-Vis spectra. The conjugates did not have a defined 
peak at 520nm, instead there was a sharp drop-off in the 580-600nm range. The naked 
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AuNP and the conjugates also had different absorbances in the 200-400nm range. The 
naked AuNP samples consistently had significantly higher absorbances throughout this 
range. These distinct changes indicate that the RNA was successfully attached to the 
gold nanoparticles. The Snm samples also displayed changes in the UV-Vis spectra, 
but they were not as distinct as those shown in the 15nm samples. The dUTP 
conjugates showed a distinct peak at 520nm, but the peak was spread over a larger 
range of wavelengths. The sample showed an increase in absorbance in the 600-
800nm range. The 2'F conjugates also displayed a wider peak at 520nm and an 
increase in absorbance in the 600-800nm range. The changes in the UV-Vis spectra 
again suggest that the attachment of the RNA to the nanoparticle was successful. 
The overall goals for this study were to increase the stability of the ykkCD 
riboswitch and to show that it can be successfully attached to well-characterized gold 
nanoparticles. Both objectives were met. The dUTP and 2'F modifications were 
effective in increasing the stability of ykkCD in the presence of ribonucleases. The 
increased stability was visualized by comparing the fraction of intact RNA over time. 
The attachment of the RNA to the nanoparticles was also successful and was shown 
several different ways. The gel shifts, dynamic light scattering, and the UV-Vis analysis 
all showed that the RNA had been successfully attached to the AuNPs. The results of 
this study will help future researchers develop a method of using ykkCD to treat 
resistant bacteria and to eventually use the unique properties of the riboswitch to 
perform other advanced therapeutic processes. 
40 
References 
1. DeLong R, Reynolds C, Malcolm Y, Schaeffer A, Severs T, Wanekaya A. 
Functionalized gold nanoparticles for the binding, stabilization, and delivery of 
therapeutic DNA, RNA, and other biological macromolecules. Nanotechnology, 
Science and Applications. 2010;3:53-63. 
2. Bui, My N. (2016). Construction of Nucleic Acid Nano-Architectures Based on 
RNA Tetra-U Linking Module. Unpublished master's thesis, Ball State University, 
Muncie, Indiana. 
3. Grabow WW, Jaeger L. RNA Self-Assembly and RNA Nanotechnology. Ace. 
Chern. Res. 2014;47:1871-1880. 
4. Medina, C., Santos-Martinez, M. J., Radomski, A., Corrigan, 0. I. and Radomski, 
M. W. (2007), Nanoparticles: pharmacological and toxicological significance. 
British Journal of Pharmacology, 150:552-558. doi:10.1038/sj.bjp.0707130 
5. Shu Y, Pi Fengmei, Sharma A, Rajabi M, Haque F, Shu D, Leggas M, Evers BM, 
Guo P. Stable RNA nanoparticles as potential 
new generation drugs for cancer therapy. Adv Drug Deliv Rev. 2014;0:74-89. 
6. Taton TA. Preparation of Gold Nanoparticle-DNA Conjugates. Current Protocols 
in Nucleic Acid Chemistry. 2002;12.2.1-12.2.12 
41 

